24,943 Shares in The Cooper Companies, Inc. $COO Acquired by AMG National Trust Bank

AMG National Trust Bank purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the first quarter, Holdings Channel reports. The fund purchased 24,943 shares of the medical device company’s stock, valued at approximately $1,783,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Wellington Management Group LLP increased its stake in shares of Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the period. Generation Investment Management LLP bought a new stake in Cooper Companies during the 4th quarter valued at $233,539,000. Diamond Hill Capital Management Inc. boosted its position in Cooper Companies by 479.6% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after buying an additional 2,720,594 shares during the period. Price T Rowe Associates Inc. MD boosted its position in Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after buying an additional 2,231,568 shares during the period. Finally, Franklin Resources Inc. grew its holdings in Cooper Companies by 108.2% in the 4th quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock worth $329,646,000 after acquiring an additional 2,089,763 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $68.51 on Wednesday. The company has a 50-day simple moving average of $65.58 and a two-hundred day simple moving average of $72.74. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The firm has a market capitalization of $13.36 billion, a PE ratio of 58.06, a price-to-earnings-growth ratio of 1.86 and a beta of 0.84. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the business earned $0.96 EPS. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have issued reports on COO shares. Citigroup restated a “neutral” rating and issued a $76.00 price objective (up from $69.00) on shares of Cooper Companies in a research report on Wednesday, July 8th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a report on Wednesday, May 27th. Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. BNP Paribas Exane lowered their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, June 8th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $81.85.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.